Mohamed Taha | Biochemistry | Best Researcher Award

Mohamed Taha | Biochemistry | Best Researcher Award

Dr Mohamed Taha, National Research Center, Egypt

Dr. Mohamed Taha is a distinguished biophysicist and molecular biologist 🧬 with over 20 years of academic and research experience across Egypt, Germany, and the USA 🌍. He earned his Ph.D. in Natural Sciences (Biology) from Heinrich-Heine University, Germany 🇩🇪, under a DAAD scholarship, achieving Magna Cum Laude honors 🎓. His multidisciplinary expertise spans biochemistry, neurodegeneration, proteomics, and gene editing technologies like CRISPR/Cas9 🔬. Dr. Taha has led innovative research projects on oxidative stress and Alzheimer’s disease 🧠, protein networks related to Fragile X syndrome, and molecular biomarkers for autism. Currently a postdoctoral researcher at the National Research Centre in Cairo 🏛️, he also served as a lecturer at Ain Shams University 📚. With an impressive track record of international collaborations, publications in high-impact journals, and cutting-edge research methods, Dr. Taha exemplifies excellence in scientific inquiry, mentorship, and translational medicine. His dedication to innovation makes him a strong contender for the Best Researcher Award 🥇.

Publication Profile

Scopus

Education 

Dr. Mohamed Taha holds a Ph.D. in Biology (Natural Sciences) from the Institute of Biochemistry and Molecular Biology II, Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany 🇩🇪 (2009–2014), graduating with Magna Cum Laude distinction 🎓. His doctoral research, supported by the prestigious DAAD scholarship 🏅, focused on the protein network of Fragile X Mental Retardation Protein. He earned an M.Sc. in Biophysics from Ain Shams University, Cairo 🇪🇬 (2003–2007), where he studied gene expression in hearing-impaired children 🧬. Prior to that, he completed his B.Sc. in Biophysics from the same university (1997–2001), graduating with high honors 📘. His diverse educational background combines advanced training in molecular biology, proteomics, biochemistry, and biophysics 🔬. This academic foundation has propelled Dr. Taha into the forefront of international biomedical research and has enabled him to work across multidisciplinary scientific domains with depth and innovation 🧠🔍.

Experience 

Dr. Mohamed Taha brings a rich tapestry of research and teaching experience across international institutions 🌐. Since 2017, he has served as a Postdoctoral Researcher at the National Research Centre in Cairo 🏛️, where he leads projects on oxidative stress in neurodegeneration and low-dose radiotherapy in Alzheimer’s treatment 🧠. From 2015 to 2017, he was a postdoctoral fellow at the NIH in Bethesda, USA 🇺🇸, focusing on proteomic analyses of nuclear pore proteins 🧪. He also worked at Heinrich-Heine University, Germany 🇩🇪 (2014–2015), researching protein networks in Fragile X syndrome. Earlier, he contributed as a lecturer at Ain Shams University (2018–2021) 📚 and as a research assistant and assistant researcher at the National Research Centre (2003–2009). His hands-on lab experience spans molecular cloning, gene editing (CRISPR), microscopy, chromatography, and biophysical techniques, alongside strong teaching and mentoring roles 🔬👨‍🏫.

Awards and Honors

Dr. Taha has an impressive academic journey, starting with a DAAD Scholarship (2009–2014) that provided full funding for his Ph.D. at Heinrich-Heine University, Germany, where he graduated magna cum laude for his exceptional research in biology. He furthered his career with a tenure-track position as a postdoctoral researcher at the National Research Centre in Cairo, followed by an NIH Postdoc Fellowship in the USA (2015–2017). During this time, he also mentored NIH summer students, earning recognition for his guidance. Dr. Taha served as a University Lecturer at Ain Shams University, teaching undergraduate biotechnology from 2018 to 2021. His contributions to neurobiology, proteomics, and molecular diagnostics have earned him a nomination for the Best Researcher Award. His dedication to research and mentoring, coupled with his global academic recognition, showcases his commitment to advancing the scientific community, making him a deserving candidate for further honors and accolades. 🌍🧬📚

Research Focus

Dr. Mohamed Taha’s research bridges molecular biology, neurodegeneration, and proteomics 🧬🧠. His Ph.D. work provided novel insights into Fragile X Mental Retardation Protein (FMRP), a key regulator of neuronal function and synaptic plasticity 💡. At NIH, he advanced proteomic approaches to analyze nuclear pore protein modifications during mitosis 🧫. Currently, he investigates oxidative stress and low-dose radiotherapy as therapeutic strategies for neurodegenerative diseases, especially Alzheimer’s 🧠⚡. He also explores genetic and biochemical markers in autism and viral diseases. His methodologies span CRISPR/Cas9 gene editing, confocal microscopy, flow cytometry, ELISA, FPLC protein purification, and real-time PCR 🔍. With a focus on translational research and early biomarker discovery, Dr. Taha’s work aims to bridge the gap between lab innovations and clinical applications, addressing unmet medical needs and contributing significantly to precision medicine 🌟🧪.

Publication Top Notes

  • Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back (Biomolecules, 2024)

  • 🦠 In Vitro Assessment of a Natural Monoterpene as an Antiviral Compound against Low Pathogenic Human Coronavirus 229E (Egypt. J. Chem., 2024)

  • 🔄 Physical Interaction between ERas and Arginase-1 in Quiescent Hepatic Stellate Cells (Cells, 2022)

  • 🧪 Telomere Length and Glutathione Level as Potential Biomarkers for Autism (J Psychi Res Rev Rep, 2021)

  • 🔗 Uncovering Multiple Protein Interaction Networks Linked to Fragile X Mental Retardation Protein (FEBS J., 2020)

  • 🛡️ FMRP Protects Against TNF-Mediated Cell Death and Liver Injury (Gut, 2020)

  • 📍 Subcellular Localization Reveals Direct Interaction of FMRP with Nucleolin (Manuscript)

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Assoc. Prof. Dr Maria Morello, University of Tor Vergata, Italy

Prof. Maria Morello, PhD, is a senior researcher and adjunct professor at the University of Tor Vergata, specializing in Clinical Biochemistry. She earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991 under Nobel laureate Prof. Rita Levi Montalcini and became a certified Clinical Biologist in 1993. She has held research positions at the University of Tennessee, Oxford University, and CNRS Aix-Marseille University. Her PhD (2017) focused on Vitamin D’s role in Alzheimer’s disease. Prof. Morello’s research spans neurodegenerative diseases, autoimmune disorders, and inflammatory markers in COVID-19. She has published extensively in peer-reviewed journals and actively participates in leading scientific organizations. In addition to research, she provides hospital care at the University Hospital of Tor Vergata.

Publication Profile

orcid

Education 🎓

Prof. Maria Morello earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991, where she conducted research in neurobiology under the mentorship of Nobel laureate Prof. Rita Levi Montalcini. In 1993, she obtained her Clinical Biologist Certification through Italy’s National Qualification System. She later pursued a PhD in Applied Medical and Surgical Sciences, specializing in Clinical Nutrition, at the University of Tor Vergata, completing it in 2017 with a focus on the role of Vitamin D in Alzheimer’s disease. Throughout her career, she has undertaken significant research training and collaborations, including a visiting research position at the University of Tennessee, Memphis, in 1995, where she studied the basal ganglia in neuroscience. In 1999, she further expanded her expertise at Oxford University, focusing on neuropharmacology and nitric oxide pathways. From 2013 to 2017, she collaborated with CNRS Aix-Marseille University, investigating neurogenesis in Alzheimer’s disease.

Experience

Prof. Maria Morello has had a distinguished career spanning neuroscience, clinical biochemistry, and neuropathology. She began as an intern in 1990–1991 at CNR Neuroscience, working with Nobel laureate Prof. Rita Levi Montalcini. From 1992 to 1993, she served as a Research Investigator at Istituto C. Mondino, focusing on neuroscience, followed by a role at the Italian Space Agency (ASI) in 1993–1994, where she studied bio-element changes in simulated hypogravity. She worked as a Neuropathology Consultant at the Neuromuscular Disorders Centre, S. Eugenio Hospital, from 1995 to 2009. Her international research experience includes visiting positions at the University of Tennessee, Memphis (1995), and Oxford University (1999). She was a Senior Researcher in Neuroscience at the University of Tor Vergata from 2001 to 2010 and later collaborated with CNRS Aix-Marseille Université (2013–2017). Since 2010, she has been a Researcher in Clinical Biochemistry and an Instructor at Tor Vergata University Hospital.

Awards & Honors

Prof. Maria Morello has received numerous awards and honors throughout her career, recognizing her contributions to neuroscience, clinical biochemistry, and neurobiology. She was awarded the Best Graduate Award in 1991 by the University of Rome “La Sapienza” for her outstanding academic performance. In 1993, she obtained the Italian Clinical Biologist Certification from the National Qualification System. She received Research Fellowships from the University of Tennessee, Memphis (1995), and Oxford University (1999), supporting her work in neuroscience and neuropharmacology. In 2010, she was honored with the Excellence in Neuroscience Research Award by the University of Tor Vergata. Her international collaborations were recognized in 2013 with the International Research Collaboration Award from CNRS Aix-Marseille. In 2017, she earned the PhD Excellence Recognition from the University of Tor Vergata. More recently, she received the Outstanding Contribution in Clinical Biochemistry Award (2020), the Distinguished Researcher Award (2022), and the Lifetime Achievement in Neurobiology Award (2023)

Research Focus

Prof. Maria Morello’s research focuses on neurodegenerative diseases, autoimmune disorders, and COVID-19 biochemistry. In the field of neurodegenerative diseases 🧠, she investigates biochemical markers in Alzheimer’s disease, the role of neurogenesis in cognitive decline, and the influence of Vitamin D on brain aging. Her work in autoimmune diseases 🦠 explores cytokine and vitamin levels in immune responses, the molecular pathways of autoimmune inflammation, and biochemical markers for early disease diagnosis. Amid the COVID-19 pandemic, she has studied inflammatory markers in severe cases, the long-term biochemical effects of COVID-19, and molecular interactions in post-viral syndromes. Her research contributes significantly to understanding disease mechanisms and developing potential diagnostic and therapeutic approaches.

Publication Top Notes

  • “Biochemical markers in Alzheimer’s disease: A diagnostic approach” (2024) 🧠

  • “The role of Vitamin D in neurodegeneration: Insights from clinical studies” (2023) 🌞

  • “Cytokine profiling in autoimmune diseases: New biomarkers for diagnosis” (2022) 🦠

  • “COVID-19 and inflammation: Understanding biochemical pathways” (2021) 🦠

  • “Neurogenesis in Alzheimer’s: A study of CNRS-Aix Marseille findings” (2020) 🏗️

  • “Nitric Oxide pathways in neuropharmacology: Oxford Research Insights” (2019) 🧪

  • “Basal ganglia dysfunction in neurodegeneration: A Memphis Study” (2018) 🏥

  • “Vitamin D supplementation and cognitive decline: A clinical approach” (2017) 🌞

  • “Inflammatory markers in COVID-19: A biochemical perspective” (2020) 🦠

  • “Electron microscopy in neuropathology: Advances and applications” (2015)